• Login
    View Item 
    •   Athenaeum Home
    • University of Georgia Theses and Dissertations
    • University of Georgia Theses and Dissertations
    • View Item
    •   Athenaeum Home
    • University of Georgia Theses and Dissertations
    • University of Georgia Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Adherence of cGMPS for atypical actives for use as active pharmaceutical ingredients

    Thumbnail
    Date
    2016-08
    Author
    Aslinger, Josh Michael
    Metadata
    Show full item record
    Abstract
    Atypical Actives play a significant role in the manufacturing of over-the-counter (OTC) and prescription (Rx) drugs. The FDA expects manufacturers of Atypical Actives to follow the ICH Q7 Guidance Document for current Good Manufacturing Practices (cGMPs); however it has been widely reported that not all Atypical Actives are manufactured in accordance with this Guidance. What do Industry Professionals think the level of cGMPs should be to manufacture Atypical Actives? To answer this question, surveys were distributed to manufacturers and industry professionals to determine if higher or lower cGMP standards were required to manufacture “Atypical Actives”. The data set revealed that respondents employed by a member company of IPEC, believe that the cGMP standards for “Atypical Actives” should not be as strict as for “typical” Active Pharmaceutical Ingredients.
    URI
    http://purl.galileo.usg.edu/uga_etd/aslinger_josh_m_201608_ms
    http://hdl.handle.net/10724/36596
    Collections
    • University of Georgia Theses and Dissertations

    About Athenaeum | Contact Us | Send Feedback
     

     

    Browse

    All of AthenaeumCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    About Athenaeum | Contact Us | Send Feedback